MSU
TERN

Mizuho Securities USA’s Terns Pharmaceuticals TERN Stock Holding History

Mizuho Securities USA’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,083
Closed -$584K – 716
2026
Q1 		$584K Buy
+11,083
New +$455K 0.01% 626

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mizuho Securities USA's TERN Position: Q2 2026 in Review

Mizuho Securities USA sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 11,083 shares — an estimated $584K sold.

Mizuho Securities USA first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $584K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Mizuho Securities USA reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Mizuho Securities USA sold 11,083 Terns Pharmaceuticals shares in Q2 2026, an estimated $584K.
  • Mizuho Securities USA first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Mizuho Securities USA's Terns Pharmaceuticals position peaked at $584K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.